Katherine Tarlock - Concepedia

Author

Katherine Tarlock

Fred Hutch Cancer Center ORCID

Also Known As

Katherine G. Tarlock, Katherine Tarlock

176

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Fred Hutch Cancer Center Seattle Children's Hospital University of Washington Children's Oncology Group University of Southern California

About

Katherine Tarlock is an author at Fred Hutch Cancer Center specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	237
2	Health Sciences	2	2	56
3	Nursing	1	1	46
4	Public Health	1	1	46
5	Blood Transplantation	1	1	46

Katherine Tarlock

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Preemptive mitigation of CD19 CAR T-cell cytokine release syndrome without attenuation of antileukemic efficacy Rebecca Gardner, Francesco Ceppi, Julie Rivers, Blood	2019	279
<i>CEBPA</i>-bZip mutations are associated with favorable prognosis in de novo AML: a report from the Children’s Oncology Group Katherine Tarlock, Adam J. Lamble, Yi‐Cheng Wang, Blood	2021	119
Acute myeloid leukaemia (<scp>AML</scp>) with t(6;9)(p23;q34) is associated with poor outcome in childhood <scp>AML</scp> regardless of <i>FLT3</i>‐ITD status: a report from the Children's Oncology Group Katherine Tarlock, Todd A. Alonzo, Pilar Palomo Moraleda, British Journal of Haematology	2014	67
Sorafenib treatment following hematopoietic stem cell transplant in pediatric <i>FLT3</i>/ITD acute myeloid leukemia Katherine Tarlock, Bill H. Chang, Todd M. Cooper, Pediatric Blood & Cancer	2015	64
Decreased Rates of Severe CRS Seen with Early Intervention Strategies for CD19 CAR-T Cell Toxicity Management Rebecca Gardner, Kasey J. Leger, Colleen Annesley, Blood	2016	62
Comprehensive molecular and clinical characterization of <i>NUP98</i> fusions in pediatric acute myeloid leukemia Eline J.M. Bertrums, Jenny L. Smith, Lauren Harmon, Haematologica GeneticsImmunologyMolecular BiologyPathologyDisease Gene Identification	2023	62
Gemtuzumab Ozogamicin Reduces Relapse Risk in <i>FLT3</i> /ITD Acute Myeloid Leukemia: A Report from the Children's Oncology Group Katherine Tarlock, Todd A. Alonzo, Robert B. Gerbing, Clinical Cancer Research	2015	60
Functional Properties of <i>KIT</i> Mutations Are Associated with Differential Clinical Outcomes and Response to Targeted Therapeutics in CBF Acute Myeloid Leukemia Katherine Tarlock, Todd A. Alonzo, Yi-Cheng Wang, Clinical Cancer Research	2019	51
Characteristics and prognostic impact of<i>IDH</i>mutations in AML: a COG, SWOG, and ECOG analysis Sara Zarnegar‐Lumley, Todd A. Alonzo, Robert B. Gerbing, Blood Advances	2023	51
CD33 CAR T-Cells (CD33CART) for Children and Young Adults with Relapsed/Refractory AML: Dose-Escalation Results from a Phase I/II Multicenter Trial Nirali N. Shah, Sarah K. Tasian, M. Eric Kohler, Blood	2023	50

Page 1